Skip to main content

Amgen cash flow statement

  • AMGN · Nasdaq
  • Biotechnology
  • S&P 500
$465.67−0.30%Close 13 Nov 2026 · Market value $253.3B

In fiscal 2025 (the year to 31 Dec 2025), Amgen generated $9.96B of operating cash flow and $8.10B of free cash flow, after $1.86B of capital expenditure.

From Amgen's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Amgen cash flow statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$3.08B$4.05B$4.61B$4.63B$3.68B$4.34B$5.08B$5.16B$6.94B$7.72B$1.98B$8.39B$7.84B$7.26B$5.89B$6.55B$6.72B$4.09B$7.71B$9.39B
Depreciation & amortization$1.20B$1.07B$1.05B$1.02B$1.06B$1.09B$1.29B$2.09B$2.11B$2.10B$1.96B$1.95B$2.21B$3.60B$3.40B$3.42B$4.07B$5.59B$5.17B$4.48B
Stock-based compensation$263.0M$262.0M$284.0M$353.0M$341.0M$362.0M$403.0M$408.0M$322.0M$311.0M$329.0M$311.0M$308.0M$330.0M$341.0M$401.0M$431.0M$530.0M$494.0M$493.0M
Operating cash flow$5.40B$5.99B$6.34B$5.79B$5.12B$5.88B$6.29B$8.95B$9.73B$10.35B$11.18B$11.30B$9.15B$10.50B$9.26B$9.72B$8.47B$11.49B$9.96B$12.04B
Operating cash flow margin36.6%39.9%43.3%38.4%32.9%34.1%33.7%44.6%44.9%45.0%48.9%47.6%39.2%41.3%35.6%36.9%30.0%34.4%27.1%30.9%
Capital expenditures$1.27B$672.0M$530.0M$580.0M$567.0M$689.0M$693.0M$718.0M$594.0M$738.0M$664.0M$738.0M$618.0M$608.0M$880.0M$936.0M$1.11B$1.10B$1.86B$2.45B
Acquisitions$697.0M$56.00M$0.00$0.00$701.0M$2.39B$9.43B$165.0M$359.0M$0.00$19.00M$195.0M$13.62B$0.00$2.53B$3.84B$26.99B$0.00$53.00M—
Free cash flow$4.13B$5.32B$5.81B$5.21B$4.55B$5.19B$5.60B$8.23B$9.14B$9.62B$10.51B$10.56B$8.53B$9.89B$8.38B$8.79B$7.36B$10.39B$8.10B$9.58B
Free cash flow margin28.0%35.4%39.7%34.6%29.2%30.1%30.0%41.0%42.2%41.8%46.0%44.5%36.5%38.9%32.3%33.4%26.1%31.1%22.0%24.6%
Free cash flow per share$3.68$4.95$5.69$5.40$4.99$6.60$7.32$10.69$11.93$12.75$14.30$15.88$14.01$16.76$14.63$16.24$13.68$19.21$14.94$17.61
Dividends paid——$0.00$0.00$500.0M$1.12B$1.42B$1.85B$2.40B$3.00B$3.37B$3.51B$3.51B$3.75B$4.01B$4.20B$4.56B$4.83B$5.12B$5.37B
Gross share repurchases$5.10B$2.27B$3.21B$3.79B$8.31B$4.61B$832.0M$138.0M$1.87B$2.96B$3.16B$17.79B$7.70B$3.49B$4.97B$6.36B$0.00$200.0M$0.00—
Stock issuance proceeds$277.0M$155.0M$171.0M$80.00M$242.0M$1.29B$296.0M$186.0M$82.00M$55.00M——————————
Net share repurchases$4.82B$2.11B$3.04B$3.71B$8.07B$3.32B$536.0M−$48.00M$1.78B$2.91B$3.16B$17.79B$7.70B$3.49B$4.97B$6.36B$0.00$200.0M$0.00—
Cash interest paid—$303.0M$293.0M$323.0M$446.0M$481.0M$1.10B$1.10B$1.00B$1.20B$1.30B$1.50B$1.30B$1.20B$1.20B$1.20B$2.40B$3.30B$2.90B—
Free cash flow after SBC$3.87B$5.05B$5.52B$4.85B$4.21B$4.83B$5.20B$7.83B$8.81B$9.30B$10.18B$10.25B$8.22B$9.56B$8.04B$8.38B$6.93B$9.86B$7.61B$9.09B

Quarterly

Amgen cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$767.0M−$113.0M$746.0M$2.83B$627.0M$1.73B$1.43B$3.22B$1.33B$1.82B$2.38B$3.86B
Depreciation & amortization$1.38B$1.40B$1.40B$1.40B$1.40B$1.39B$1.32B$1.33B$1.13B$1.12B$1.11B$1.12B
Stock-based compensation$161.0M$103.0M$157.0M$136.0M$134.0M$85.00M$157.0M$127.0M$125.0M$75.00M$165.0M$128.0M
Operating cash flow$538.0M$689.0M$2.46B$3.57B$4.77B$1.39B$2.28B$4.68B$1.60B$2.19B$4.00B$4.24B
Operating cash flow margin6.6%9.3%29.3%42.0%52.5%17.1%24.8%49.0%16.2%25.4%39.8%40.9%
Capital expenditures$249.0M$230.0M$238.0M$257.0M$371.0M$411.0M$369.0M$436.0M$642.0M$712.0M$513.0M$587.0M
Free cash flow$289.0M$459.0M$2.22B$3.31B$4.40B$980.0M$1.91B$4.25B$961.0M$1.48B$3.49B$3.65B
Free cash flow margin3.5%6.2%26.5%39.0%48.4%12.0%20.8%44.4%9.7%17.1%34.7%35.3%
Free cash flow per share$0.54$0.86$4.11$6.11$8.13$1.81$3.53$7.84$1.77$2.72$6.41$6.69
Dividends paid$1.14B$1.21B$1.21B$1.21B$1.21B$1.28B$1.28B$1.28B$1.28B$1.36B$1.36B$1.36B
Gross share repurchases$0.00———————————
Net share repurchases$0.00———————————
Free cash flow after SBC$128.0M$356.0M$2.06B$3.18B$4.27B$895.0M$1.75B$4.12B$836.0M$1.40B$3.32B$3.53B

The main figures as JSON and plain text. See data and methodology.

AMGN in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.